Elite Health Systems Inc. (EHSI) — SEC Filings
Elite Health Systems Inc. (EHSI) — 22 SEC filings. Latest: 10-K (Apr 15, 2026). Includes 12 8-K, 6 10-Q, 3 10-K.
View Elite Health Systems Inc. on SEC EDGAR
Overview
Elite Health Systems Inc. (EHSI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 13, 2025: Elite Health Systems Inc. (EHSI) reported no revenue for the nine months ended September 30, 2025, and 2024, continuing its pre-revenue phase. The company incurred a net loss of $2,026,000 for the nine months ended September 30, 2025, a significant increase from the $1,034,000 net loss in the same p
Sentiment Summary
Across 22 filings, the sentiment breakdown is: 2 bearish, 20 neutral. The dominant filing sentiment for Elite Health Systems Inc. is neutral.
Filing Type Overview
Elite Health Systems Inc. (EHSI) has filed 3 10-K, 6 10-Q, 12 8-K, 1 10-K/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (22)
Risk Profile
Risk Assessment: Of EHSI's 20 recent filings, 2 were flagged as high-risk, 13 as medium-risk, and 5 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $0 |
| Net Income | -$2,026,000 |
| EPS | -$0.09 |
| Debt-to-Equity | 0.06 |
| Cash Position | $3,970,000 |
| Operating Margin | N/A |
| Total Assets | $5,311,000 |
| Total Debt | $291,000 |
Key Executives
- Roa RYalamanchili
- Leimkuhler
- St. Lawrence
Industry Context
The health insurance industry, particularly the Medicare Advantage segment, is highly regulated and competitive. Companies must navigate complex compliance requirements and demonstrate value to beneficiaries and the government. Growth in Medicare Advantage is driven by an aging population and the comprehensive benefits offered compared to traditional Medicare. Success hinges on efficient operations, strong provider networks, and effective marketing.
Top Tags
material-agreement (4) · material-definitive-agreement (4) · 10-Q (4) · financials (3) · U.S. NeuroSurgical Holdings (3) · SEC Filing (3) · Healthcare (2) · Medicare Advantage (2) · Going Concern (2) · 8-k (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $2,026,000 | For the nine months ended September 30, 2025, a significant increase from $1,034,000 in 2024. |
| Revenue | $0 | For the nine months ended September 30, 2025 and 2024, indicating pre-revenue status. |
| Accumulated Deficit | $6,471,000 | As of September 30, 2025, up from $4,445,000 at December 31, 2024. |
| Capital Raised | $5,825,000 | Through private sale of 11,650,000 common shares completed January 2025. |
| Common Shares Outstanding | 21,939,924 | As of October 31, 2025, reflecting significant dilution from prior periods. |
| Capitalized Software Under Development | $992,000 | As of September 30, 2025, up from $0 at December 31, 2024, reflecting investment in new business. |
| Expected Revenue Commencement | January 2026 | From Medicare Advantage Plan operations. |
| Filing Date | 20251105 | Date the 8-K was filed with the SEC. |
| Report Date | 20251031 | The date as of which the earliest event reported in the filing occurred. |
| Net Loss (Q2 2025) | -$441,000 | Increased from -$435,000 in Q2 2024, reflecting ongoing operational costs without revenue. |
| Net Loss (H1 2025) | -$865,000 | Increased from -$747,000 in H1 2024, showing growing losses as the company develops. |
| Cash and Cash Equivalents | $3,121,000 | Decreased from $4,034,000 at Dec 31, 2024, indicating cash burn for operations. |
| Knox-Keene License Awarded | May 2025 | Key regulatory approval for operating managed health care plans in California. |
| CMS Conditional Approval | June 2025 | Critical step towards operating a Medicare Advantage plan for CY 2026. |
| Planned Private Placement | $2,000,000 - $5,000,000 | Expected proceeds from a July 2025 offering, vital for continued funding. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Elite Health Systems Inc. (EHSI)?
Elite Health Systems Inc. has 22 recent SEC filings from Jan 2024 to Apr 2026, including 12 8-K, 6 10-Q, 3 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of EHSI filings?
Across 22 filings, the sentiment breakdown is: 2 bearish, 20 neutral. The dominant sentiment is neutral.
Where can I find Elite Health Systems Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Elite Health Systems Inc. (EHSI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Elite Health Systems Inc.?
Key financial highlights from Elite Health Systems Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for EHSI?
The investment thesis for EHSI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Elite Health Systems Inc.?
Key executives identified across Elite Health Systems Inc.'s filings include Roa RYalamanchili, Leimkuhler, St. Lawrence.
What are the main risk factors for Elite Health Systems Inc. stock?
Of EHSI's 20 assessed filings, 2 were flagged high-risk, 13 medium-risk, and 5 low-risk.
What are recent predictions and forward guidance from Elite Health Systems Inc.?
Forward guidance and predictions for Elite Health Systems Inc. are extracted from SEC filings as they are enriched.